Skip to main content

New Report Reveals Best Practices and Benchmarks for Health System Specialty Pharmacy Service Clinical Measurement in 2023

Trellis Rx, LLC's 'Patient Impact Report' returns for second year with new and expanded best practices for specialty pharmacy patient outcomes and performance measurement

2023 Patient Impact Report
2023 Patient Impact Report

Clinical Outcomes Measures for Health System Specialty Pharmacy Services

Trellis Rx, LLC, a leading technology-enabled service provider for health system specialty pharmacies (HSSPs) now part of CPS Solutions, LLC's family of companies, today published the second edition of its annual "Patient Impact Report," an industry guide for measuring HSSP clinical outcomes. Building on last year's inaugural report — the first of its kind for HSSPs — this year's edition offers expanded, evidence-backed clinical standards for measuring HSSP performance. It also introduces new strategies for benchmarking the specialty pharmacy's clinical impact on patients living with common chronic conditions like asthma. 

"HSSP growth is booming, but the industry's clinical outcomes measurement strategies are still maturing. This means it's often difficult for leaders to show service impact consistently and effectively," said Brandon Newman, PharmD, MMHC, CSP, Chief Operating Officer and General Manager of Trellis Rx. "Pioneers in the industry are already using this report's research and best practices to demonstrate success. Sharing these proven strategies benefits HSSP clinical practice, health system growth, and most importantly, the lives of patients we serve."

The Patient Impact Report compiles clinical protocols, outcomes research, and measurement best practices into a proven framework health system and pharmacy leaders can use to benchmark their HSSP's clinical impact and value. Daily, specialty pharmacy teams at Trellis Rx's network of partner health systems use advanced technology and workflows to gather robust data and insights around HSSP patient needs, intervention outcomes, and therapeutic results. The data was aggregated and deidentified for inclusion in the report, with interesting findings flagged for a dedicated study by Trellis Rx's Outcomes Program clinical research team. 

Key Findings

Highlights from the report include:

  • The latest benchmarks and best practices in HSSP clinical outcomes measurement for patients living with complex specialty conditions like cancer, multiple sclerosis, and more. 
  • New information for expanding HSSP services and driving clinical improvements for patients who live with common chronic conditions, such as asthma and diabetes.
  • Recent research evaluating how HSSPs reduce inappropriate discontinuations for patients prescribed oral oncolytics, improve severity categories for patients with autoimmune diseases, accelerate therapy state times for patients with Hepatitis C, and more. 

Download the report to learn how you can improve HSSP clinical outcomes measurement to drive growth and elevate patient care. 

About Trellis Rx, LLC

Trellis Rx, LLC, now part of the CPS family of companies, is a complete specialty pharmacy services solution for health systems looking to enhance the medication therapy experience and drive market-leading clinical outcomes for their patients with chronic and complex conditions. Working side by side with health systems, Trellis Rx delivers everything required to rapidly build and expand fully integrated specialty pharmacy services through a performance-based partnership model designed to ensure results. To learn more about Trellis Rx, visit www.trellisrx.com

About CPS Solutions, LLC 

Founded nearly 50 years ago, CPS Solutions, LLC (CPS) is one of the nation's largest providers of pharmacy and hospital services — employing over 2,500 pharmacy and healthcare professionals and servicing over 800 hospitals and healthcare facilities nationwide. CPS helps clients tackle complex problems through our suite of solutions across the care continuum. CPS solutions include inpatient pharmacy solutions and specialty and ambulatory pharmacy solutions, pharmacy consulting, 340B services, telepharmacy services, supply chain and materials management services, rehabilitation services, and more. CPS empowers healthcare organizations to achieve operational excellence, drive clinical quality, attain continuous regulatory compliance, and improve bottom-line performance — all while supporting staff, caregivers, patients, and their communities. For more information, visit cps.com.   

Contact Information:
Rod Recor
Chief Marketing Officer
rod.recor@cps.com
614.420.1385


Original Source: New Report Reveals Best Practices and Benchmarks for Health System Specialty Pharmacy Service Clinical Measurement in 2023
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.